Unknown

Dataset Information

0

An optimized, amplicon-based approach for sequencing of SARS-CoV-2 from patient samples using COVIDSeq assay on Illumina MiSeq sequencing platforms.


ABSTRACT: Sequencing of SARS-CoV-2 genomes is crucial for understanding the genetic epidemiology of the COVID-19 pandemic. It is also critical for understanding the evolution of the virus and also for the rapid development of diagnostic tools. The present protocol is a modification of the Illumina COVIDSeq test. We describe an amplicon-based next-generation sequencing approach with short turnaround time, adapted for bench-top sequencers like MiSeq, iSeq, and MiniSeq. For complete details on the use and execution of this protocol, please refer to Bhoyar et al. (2021).

SUBMITTER: Bhoyar RC 

PROVIDER: S-EPMC8326003 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5409056 | biostudies-literature
| S-EPMC6791344 | biostudies-literature
| S-EPMC4381044 | biostudies-literature
| S-EPMC10048438 | biostudies-literature
| S-EPMC10501585 | biostudies-literature
| S-EPMC4850673 | biostudies-literature
| S-EPMC3753973 | biostudies-literature
| S-EPMC3431227 | biostudies-literature
| PRJEB76241 | ENA
| S-EPMC4580234 | biostudies-literature